Table 3.
Intervention effect on nutritional blood markers and homocysteine
| Blood outcome parameter | Mean estimated value at week 4 | Difference between groups at week 4 | p Value for intervention effect | |
|---|---|---|---|---|
| Test (n = 16) | Control (n = 17) | |||
| Fatty acids in the erythrocyte membrane | ||||
| DHA, % | 4.9 | 2.8 | 2.1 (1.84 to 2.30) | <0.001 |
| EPA, % | 1.7 | 0.8 | 0.8 (0.69 to 0.98) | <0.001 |
| DPA, % | 1.6 | 1.6 | 0.014 (−0.12 to 0.15) | 0.840 |
| LC-PUFA (DHA + EPA + DPA), % | 8.2 | 5.3 | 2.9 (2.51 to 3.24) | <0.001 |
| Fatty acids in blood plasma | ||||
| DHA, % | 4.4 | 1.5 | 2.9 (2.59 to 3.12) | <0.001 |
| EPA, % | 2.1 | 0.8 | 1.3 (1.10 to 1.51) | <0.001 |
| DPA, % | 0.50 | 0.49 | 0.008 (−0.03 to 0.04) | 0.628 |
| LC-PUFA (DHA + EPA + DPA), % | 7.0 | 2.8 | 4.2 (3.79 to 4.53) | <0.001 |
| Choline levels in blood plasma, μM | 14.4 | 9.0 | 5.4 (3.39 to 7.47) | <0.001 |
| Vitamin E levels in blood plasma, μM | 50.9 | 39.6 | 11.4 (6.77 to 15.96) | <0.001 |
| Homocysteine levels in blood plasma, μM | 9.8 | 12.4 | −2.6 (−4.31 to -0.82) | 0.006 |
| Uridine levels in blood plasma, μM | 14.8 | 2.6 | 12.2 (7.24 to 17.11) | <0.001 |
Abbreviations: DHA Docosahexaenoic acid, EPA Eicosapentaenoic acid, DPA Docosapentaenoic acid, LC-PUFA Long-chain polyunsaturated fatty acids
The 95% CI is presented in parentheses